Form 4: Haemonetics Officer's Stock Transaction for Tax Obligations

Haemonetics EVP, Chief Commercial Officer Roy Galvin reported a transaction involving shares withheld for tax obligations related to RSU vesting.

Summary

• Roy Galvin, Executive Vice President and Chief Commercial Officer of Haemonetics Corp (HAE), reported a transaction on October 31, 2025.
• 145 shares of Common Stock were disposed of at a price of $50.01 per share.
• These shares were withheld to cover tax obligations associated with the vesting of previously reported restricted stock units (RSUs).
• Following this transaction, Roy Galvin beneficially owns 12,811 shares of Common Stock.
• The 12,811 shares include previously reported unvested RSUs and 24 shares acquired by Mr. Galvin under the Issuer's 2007 Employee Stock Purchase Plan on October 31, 2025.

Sentiment

Score: 5

Explanation: The transaction primarily involves shares withheld for tax obligations upon RSU vesting, which is a routine event. The acquisition of 24 shares through an ESPP is a minor positive, indicating continued executive participation.

Positives

• Acquisition of 24 shares under the Employee Stock Purchase Plan indicates continued participation and potential confidence in the company by an executive.

Negatives

• Disposal of 145 shares, although for tax purposes, represents a reduction in direct beneficial ownership.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• The transaction involves an executive (Roy Galvin) and the company (Haemonetics Corp) related to compensation (RSU vesting and ESPP acquisition), which are standard related-party dealings in the context of executive compensation.

Stakeholder Impact

• Shareholders: The transaction is a routine compensation event, with shares withheld for tax obligations upon RSU vesting. The acquisition of a small number of shares through an ESPP shows continued executive alignment.
• Employees: The RSU vesting and Employee Stock Purchase Plan are part of the company's broader employee compensation and incentive programs.

Key Dates

Recommendation

This Form 4 details a routine insider transaction where shares were withheld for tax obligations upon the vesting of restricted stock units. A small number of shares were also acquired through an employee stock purchase plan. These types of transactions are generally not indicative of significant changes in company fundamentals or future prospects and do not typically warrant a change in investment recommendation.

Keywords

Haemonetics, HAE, Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, RSU, Employee Stock Purchase Plan, ESPP, Executive Compensation, Roy Galvin